Die Aktienkurse der Medikamentenhersteller fallen, dabei profitieren sie von Ausnahmen im US-Zollkrieg. Pharma-Experte Markus Manns weiß, was die Anleger fürchten.

was durch unserer Einschätzung nach schwächere Ergebnisse im ersten Quartal noch verstärkt wird.“ Es ist zu beachten, dass die Eli Lilly-Aktie Novo Nordisk in den letzten 12 Monaten bereits ...

Trend sorgt für Lieferengpässe Von der hohen Nachfrage nach der Abnehmspritze profitiert der Hersteller Novo Nordisk, der seit Jahren deshalb mehr Umsatz ... Pharmariesen Eli Lilly soll ...

Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly (NYSE: LLY). But now, an investment in Lilly may not look so enticing as the possibility of more tariffs loom.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best American dividend stocks. Dividend-paying stocks have long benefited investors by ...

Eli Lilly's stock price rise of 9% YTD might not look like a lot on its own, but in the context of the recent market decline, it's still a standout performance. With no end in sight for market ...

And Lilly just took a major step in the right direction. Did Eli Lilly just say checkmate to Novo Nordisk? Let's find out. So, first a quick bit about how this class of drugs works. Novo Nordisk's ...

Eli Lilly stocks displayed a major rise after the announcement of a new oral weight-loss drug that has put pressure on its rival pharmaceutical companies Eli Lilly’s stock surged 16% after the ...

Orforglipron, an experimental treatment Eli Lilly is developing for diabetes and weight loss, hit high marks in the first of several pivotal trials. The daily tablet produced blood-sugar ...

Eli Lilly stock (NYSE: LLY) stock is showing positive momentum on Thursday, April 17th, following the company’s announcement of successful results from the first of its late-stage trials for a ...